Abstract

BackgroundMedical intervention for patients with IgA nephropathy and mild proteinuria (<1.0 g/day) is controversial, and the effectiveness of tonsillectomy plus steroid pulse therapy (TSP) for such patients remains obscure.MethodsAmong 323 patients in our multicenter cohort study, 79 who had mild proteinuria (0.4–1.0 g/day) at diagnosis were eligible to participate in this study. We compared the clinicopathological findings at diagnosis, a decline in renal function defined as a 50 or 100 % increase in serum creatinine (sCr) and clinical remission (CR) defined as the disappearance of hematuria and proteinuria (<0.3 g/day) among groups given TSP (n = 46), steroid therapy (ST) (n = 9), and non-ST (n = 24). Factors contributing to CR were also evaluated using multivariate analysis.ResultsBackground factors at diagnosis including age, ratio (%) of patients with hypertension, sCr, proteinuria, and histological severity did not significantly differ among the groups. Only two patients each in the TSP (4.3 %) and non-ST (8.3 %) groups achieved a 50 % increase in sCr during a mean follow–up period of 4.7 years. At the final observation, 71.7, 44.4, and 41.7 % of patients in the TSP, ST, and non-ST groups, respectively, achieved CR (p = 0.032). Cox proportional hazards models revealed that TSP led to CR more effectively than non-TSP by a factor of about threefold (hazard ratio, 2.74; p = 0.008).ConclusionTSP therapy has potential for inducing CR in patients with IgAN and mild proteinuria (<1.0 g/day).

Highlights

  • Immunoglobulin A nephropathy (IgAN) is prominently associated worldwide with kidney disease as it occurs at high frequency in patients with glomerulonephritis [1, 2]

  • Cox proportional hazards models revealed that tonsillectomy plus steroid pulse (TSP) led to clinical remission (CR) more effectively than non-TSP by a factor of about threefold

  • Histological severity estimated using the second and third versions of the grading systems did not significantly differ, the ratios of H-Grade I group with acute (A) and acute/chronic (A/C) lesions were higher in the TSP, than in the other two groups

Read more

Summary

Introduction

Immunoglobulin A nephropathy (IgAN) is prominently associated worldwide with kidney disease as it occurs at high frequency in patients with glomerulonephritis [1, 2]. It is the leading cause of glomerulonephritis in the Japan-Renal Biopsy Registry database, where it accounts for 30 % of all registered patients [3]. It has a worse renal prognosis with 30 to 40 % of affected patients reaching end-stage kidney disease (ESKD) within 20 years [4], a disease-specific treatment modality has not yet been established [5]. Factors contributing to CR were evaluated using multivariate analysis

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call